Although the prevalence of TP53 gene alterations in asymptomatic individuals is relatively low, chronic lymphocytic leukemia is currently the best-known example of the clinical significance of TP53 status. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.